Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A complex of three natural anti-inflammatory agents provides relief of osteoarthritis pain.
Conrozier T, Mathieu P, Bonjean M, Marc JF, Renevier JL, Balblanc JC. Conrozier T, et al. Among authors: balblanc jc. Altern Ther Health Med. 2014 Winter;20 Suppl 1:32-7. Altern Ther Health Med. 2014. PMID: 24473984 Clinical Trial.
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.
Klopfenstein T, Zayet S, Lohse A, Balblanc JC, Badie J, Royer PY, Toko L, Mezher C, Kadiane-Oussou NJ, Bossert M, Bozgan AM, Charpentier A, Roux MF, Contreras R, Mazurier I, Dussert P, Gendrin V, Conrozier T; HNF Hospital Tocilizumab multidisciplinary team. Klopfenstein T, et al. Among authors: balblanc jc. Med Mal Infect. 2020 Aug;50(5):397-400. doi: 10.1016/j.medmal.2020.05.001. Epub 2020 May 6. Med Mal Infect. 2020. PMID: 32387320 Free PMC article.
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
Lohse A, Klopfenstein T, Balblanc JC, Royer PY, Bossert M, Gendrin V, Charpentier A, Bozgan AM, Badie J, Bourgoin C, Contreras R, Mazurier I, Conrozier T, Zayet S. Lohse A, et al. Among authors: balblanc jc. Microbes Infect. 2020 Jun 20:S1286-4579(20)30123-4. doi: 10.1016/j.micinf.2020.06.005. Online ahead of print. Microbes Infect. 2020. PMID: 32574789 Free PMC article.
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.
Conrozier T, Lohse A, Balblanc JC, Dussert P, Royer PY, Bossert M, Bozgan AM, Gendrin V, Charpentier A, Toko L, Badie J, Mezher C, Roux MF, Kadiane-Oussou NJ, Contreras R, Kessler J, Mazurier I, Klopfenstein T, Zayet S. Conrozier T, et al. Among authors: balblanc jc. Clin Exp Rheumatol. 2020 Jul-Aug;38(4):742-747. Epub 2020 Jun 23. Clin Exp Rheumatol. 2020. PMID: 32573419 Free article.
Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial.
Conrozier T, Eymard F, Afif N, Balblanc JC, Legré-Boyer V, Chevalier X; Happyvisc Study Group. Conrozier T, et al. Among authors: balblanc jc. Knee. 2016 Oct;23(5):842-8. doi: 10.1016/j.knee.2016.05.015. Epub 2016 Jun 25. Knee. 2016. PMID: 27353769 Clinical Trial.
Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO₂ ) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study.
Henrotin Y, Chevalier X, Deberg M, Balblanc JC, Richette P, Mulleman D, Maillet B, Rannou F, Piroth C, Mathieu P, Conrozier T; Osteoarthritis Group of French Society of Rheumatology. Henrotin Y, et al. Among authors: balblanc jc. J Orthop Res. 2013 Jun;31(6):901-7. doi: 10.1002/jor.22297. Epub 2013 Feb 19. J Orthop Res. 2013. PMID: 23423846 Clinical Trial.
Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study.
Conrozier T, Balblanc JC, Richette P, Mulleman D, Maillet B, Henrotin Y, Rannou F, Piroth C, Hilliquin P, Mathieu P, Walliser-Lohse A, Rousselot I, Plattner V, Maillefert JF, Vignon E, Chevalier X; Osteoarthritis Group of the French Society of Rheumatology. Conrozier T, et al. Among authors: balblanc jc. J Orthop Res. 2012 May;30(5):679-85. doi: 10.1002/jor.21580. Epub 2011 Oct 24. J Orthop Res. 2012. PMID: 22025307 Clinical Trial.
Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study).
Fautrel B, Pham T, Alfaiate T, Gandjbakhch F, Foltz V, Morel J, Dernis E, Gaudin P, Brocq O, Solau-Gervais E, Berthelot JM, Balblanc JC, Mariette X, Tubach F. Fautrel B, et al. Among authors: balblanc jc. Ann Rheum Dis. 2016 Jan;75(1):59-67. doi: 10.1136/annrheumdis-2014-206696. Epub 2015 Jun 23. Ann Rheum Dis. 2016. PMID: 26103979 Clinical Trial.
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.
Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P. Gottenberg JE, et al. Among authors: balblanc jc. JAMA. 2016 Sep 20;316(11):1172-1180. doi: 10.1001/jama.2016.13512. JAMA. 2016. PMID: 27654603
Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol.
Conrozier T, Bozgan AM, Bossert M, Sondag M, Lohse-Walliser A, Balblanc JC. Conrozier T, et al. Among authors: balblanc jc. Clin Med Insights Arthritis Musculoskelet Disord. 2016 Sep 25;9:175-9. doi: 10.4137/CMAMD.S39432. eCollection 2016. Clin Med Insights Arthritis Musculoskelet Disord. 2016. PMID: 27688712 Free PMC article.
37 results
Jump to page
Feedback